Rise and fall of anti-obesity drugs.

@article{Li2011RiseAF,
  title={Rise and fall of anti-obesity drugs.},
  author={Ming-fang Li and Bernard Man Yung Cheung},
  journal={World journal of diabetes},
  year={2011},
  volume={2 2},
  pages={19-23}
}
Although it is not generally a life-threatening disease, obesity is becoming a major health problem worldwide. It can be controlled by means of drugs, and, consequently, these are required to be safe as well as effective. In this paper, we summarize the fate of various drugs that have been introduced for clinical use in the treatment of obesity. Fenfluramine and dexfenfluramine were withdrawn because of heart valve damage. Sibutramine suppresses appetite and increases heart rate and blood… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

Binge eating in pre-clinical models.

View 4 Excerpts
Highly Influenced

Obesity Pharmacotherapy: Current Perspectives and Future Directions

Current cardiology reviews • 2013
View 4 Excerpts
Highly Influenced

Factors involved in white-to-brown adipose tissue conversion and in thermogenesis: a review.

Obesity reviews : an official journal of the International Association for the Study of Obesity • 2017
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Pharmacotherapy for obesity.

British journal of clinical pharmacology • 2009

Similar Papers

Loading similar papers…